MetLife Investment Advisors »

Black Diamond Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $97k 22k 4.35
2024-06-30 $45k 9.7k 4.66
2021-03-31 $198k 8.1k 24.26
2020-12-31 $261k 8.1k 32.03
2020-09-30 $246k 8.1k 30.19
2020-06-30 $266k 6.3k 42.11
2020-03-31 $158k 6.3k 24.95